150 related articles for article (PubMed ID: 3328519)
1. Peroxisomal disorders.
Gordon N
Brain Dev; 1987; 9(6):571-5. PubMed ID: 3328519
[TBL] [Abstract][Full Text] [Related]
2. Neonatal adrenoleukodystrophy. Impaired plasmalogen biosynthesis and peroxisomal beta-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts.
Wanders RJ; Schutgens RB; Schrakamp G; Tager JM; Van den Bosch H; Moser AB; Moser HW
J Neurol Sci; 1987 Feb; 77(2-3):331-40. PubMed ID: 3819771
[TBL] [Abstract][Full Text] [Related]
3. The peroxisome: nervous system role of a previously underrated organelle. The 1987 Robert Wartenberg lecture.
Moser HW
Neurology; 1988 Oct; 38(10):1617-27. PubMed ID: 2458548
[No Abstract] [Full Text] [Related]
4. Impaired ability of peroxisomes to activate very-long-chain fatty acids in X-linked adrenoleukodystrophy.
Wanders RJ; van Roermund CW; Schutgens RB; van den Bosch H; Tager JM
Lancet; 1988 Jul; 2(8603):170. PubMed ID: 2899227
[No Abstract] [Full Text] [Related]
5. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.
Singh I; Moser AE; Goldfischer S; Moser HW
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4203-7. PubMed ID: 6588384
[TBL] [Abstract][Full Text] [Related]
6. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
7. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
[TBL] [Abstract][Full Text] [Related]
8. [Peroxisomal disorders; newer concept and recent studies].
Kamoshita S
Nihon Rinsho; 1990 Mar; 48(3):629-38. PubMed ID: 2192101
[No Abstract] [Full Text] [Related]
9. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
[TBL] [Abstract][Full Text] [Related]
10. Adrenoleukodystrophy and Zellweger syndrome.
Moser HW; Moser AB; Chen WW; Watkins PA
Prog Clin Biol Res; 1990; 321():511-35. PubMed ID: 2183241
[No Abstract] [Full Text] [Related]
11. X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters.
Wanders RJ; van Roermund CW; van Wijland MJ; Nijenhuis AA; Tromp A; Schutgens RB; Brouwer-Kelder EM; Schram AW; Tager JM; van den Bosch H
Clin Chim Acta; 1987 Jun; 165(2-3):321-9. PubMed ID: 3652454
[TBL] [Abstract][Full Text] [Related]
12. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.
Chen WW; Watkins PA; Osumi T; Hashimoto T; Moser HW
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1425-8. PubMed ID: 3469675
[TBL] [Abstract][Full Text] [Related]
13. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids.
Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; van den Bosch H; Schram AW; Tager JM
Biochem Biophys Res Commun; 1988 Jun; 153(2):618-24. PubMed ID: 3382393
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
15. Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy.
Vamecq J; Draye JP; Van Hoof F; Misson JP; Evrard P; Verellen G; Eyssen HJ; Van Eldere J; Schutgens RB; Wanders RJ
Am J Pathol; 1986 Dec; 125(3):524-35. PubMed ID: 2879480
[TBL] [Abstract][Full Text] [Related]
16. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
17. Adrenoleukodystrophy and other peroxisomal disorders that affect the nervous system, including new observations on L-pipecolic acid oxidase in primates.
Moser HW; Mihalik SJ; Watkins PA
Brain Dev; 1989; 11(2):80-90. PubMed ID: 2653074
[TBL] [Abstract][Full Text] [Related]
18. Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy.
Hashmi M; Stanley W; Singh I
FEBS Lett; 1986 Feb; 196(2):247-50. PubMed ID: 3948997
[TBL] [Abstract][Full Text] [Related]
19. In situ genetic complementation analysis of cells with generalized peroxisomal dysfunction.
Singh AK; Kulvatunyou N; Singh I; Stanley WS
Hum Hered; 1989; 39(5):298-301. PubMed ID: 2482247
[TBL] [Abstract][Full Text] [Related]
20. [X-linked adrenoleukodystrophy and other peroxisomal diseases caused by a failing peroxisomal beta-oxidation system: clinical expression, diagnosis and treatment].
Wanders RJ; Barth PG; Schutgens RB; Van den Bosch H; Tager JM; Stroink H; Przyrembel H; Heymans HS
Tijdschr Kindergeneeskd; 1989 Oct; 57(5):186-97. PubMed ID: 2683204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
